Khalid Bajou
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 24
- Cancer, Hypoxia, and Metabolism 3
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 9
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 17
- Oncology top 5%
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 8
-
- Nanoparticles: synthesis and applications 5
- Advanced Nanomaterials in Catalysis 3
-
- Retinal Diseases and Treatments 4
- Co-authors
- Agnès NoëlPeter CarmelietVéronique MassonJean‐Michel FoidartRobert D. GerardLaetitia DevyNorbert E. FusenigNils Brünner
- Journals
- The FASEB Journal (5 papers)International Journal of Molecular Sciences (3 papers)Oncogene (2 papers)
- Partner nations
- BelgiumUnited Arab EmiratesUnited States
In The Last Decade
Khalid Bajou
41 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 1.6k
- Immunology and Allergy 581
- Hematology 704
- Oncology 627
- Molecular Biology 1.4k
Countries citing papers authored by Khalid Bajou
This map shows the geographic impact of Khalid Bajou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Bajou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Bajou more than expected).
Fields of papers citing papers by Khalid Bajou
This network shows the impact of papers produced by Khalid Bajou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Bajou. The network helps show where Khalid Bajou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Khalid Bajou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 4 | |
| 4 | 2020 | 19 | |
| 5 | 2019 | 34 | |
| 6 | 2019 | 2 | |
| 7 | 2017 | 7 | |
| 8 | 2014 | 34 | |
| 9 | 2008 | 123 | |
| 10 | 2007 | 15 | |
| 11 | 2005 | 35 | |
| 12 | 2003 | 104 | |
| 13 | 2002 | 30 | |
| 14 | 2002 | 117 | |
| 15 | 1998 | 37 | |
| 16 | 1998 | 27 | |
| 17 | Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularizationbreakdown → | 1998 | 574 |
| 18 | 1997 | 49 | |
| 19 | 1997 | 233 | |
| 20 | 1997 | 25 |
About Khalid Bajou
Khalid Bajou is a scholar working on Cancer Research, Hematology, Immunology and Allergy, Ophthalmology and Sensory Systems, having authored 42 papers that have together received 3.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (24 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers), Cell Adhesion Molecules Research (9 papers), Angiogenesis and VEGF in Cancer (8 papers), Nanoparticles: synthesis and applications (5 papers), Retinal Diseases and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Cancer Research (1.6k citations), Immunology and Allergy (581 citations), Hematology (704 citations), Oncology (627 citations) and Molecular Biology (1.4k citations). Khalid Bajou has collaborated with scholars based in Belgium, United Arab Emirates and United States. Frequent co-authors include Agnès Noël, Peter Carmeliet, Véronique Masson, Jean‐Michel Foidart, Robert D. Gerard, Laetitia Devy, Norbert E. Fusenig, Nils Brünner, D Collen and Silvia Blacher. Their work appears in journals such as The FASEB Journal, International Journal of Molecular Sciences, Oncogene, Biochemical and Biophysical Research Communications and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.